Cargando…

MAdCAM-1 costimulation in the presence of retinoic acid and TGF-β promotes HIV infection and differentiation of CD4(+) T cells into CCR5(+) T(RM)-like cells

CD4(+) tissue resident memory T cells (T(RM)s) are implicated in the formation of persistent HIV reservoirs that are established during the very early stages of infection. The tissue-specific factors that direct T cells to establish tissue residency are not well defined, nor are the factors that est...

Descripción completa

Detalles Bibliográficos
Autores principales: Vimonpatranon, Sinmanus, Goes, Livia R., Chan, Amanda, Licavoli, Isabella, McMurry, Jordan, Wertz, Samuel R., Arakelyan, Anush, Huang, Dawei, Jiang, Andrew, Huang, Cindy, Zhou, Joyce, Yolitz, Jason, Girard, Alexandre, Van Ryk, Donald, Wei, Danlan, Hwang, Il Young, Martens, Craig, Kanakabandi, Kishore, Virtaneva, Kimmo, Ricklefs, Stacy, Darwitz, Benjamin P., Soares, Marcelo A., Pattanapanyasat, Kovit, Fauci, Anthony S., Arthos, James, Cicala, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032498/
https://www.ncbi.nlm.nih.gov/pubmed/36897929
http://dx.doi.org/10.1371/journal.ppat.1011209
Descripción
Sumario:CD4(+) tissue resident memory T cells (T(RM)s) are implicated in the formation of persistent HIV reservoirs that are established during the very early stages of infection. The tissue-specific factors that direct T cells to establish tissue residency are not well defined, nor are the factors that establish viral latency. We report that costimulation via MAdCAM-1 and retinoic acid (RA), two constituents of gut tissues, together with TGF-β, promote the differentiation of CD4(+) T cells into a distinct subset α(4)β(7)(+)CD69(+)CD103(+) T(RM)-like cells. Among the costimulatory ligands we evaluated, MAdCAM-1 was unique in its capacity to upregulate both CCR5 and CCR9. MAdCAM-1 costimulation rendered cells susceptible to HIV infection. Differentiation of T(RM)-like cells was reduced by MAdCAM-1 antagonists developed to treat inflammatory bowel diseases. These finding provide a framework to better understand the contribution of CD4(+) T(RM)s to persistent viral reservoirs and HIV pathogenesis.